Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
No Fast Track For Lecanemab In EU Disappoints Eisai
Pan-EU Approval Could Come In March 2024, Says Company
Jan 19 2023
•
By
Andrew McConaghie
Lecanemab could be approved in the European Union by March 2024 - well over a year after the US accelerated approval. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Clinical Trials
More from R&D